Literature DB >> 26660639

Do low-dose anti-TNF regimens have a role in patients with ankylosing spondylitis?

Max Yates1, Andrew Keat1, Karl Gaffney2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26660639     DOI： 10.1093/rheumatology/kev411

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  2 in total

1.  Treatment pattern, satisfaction, and productivity loss of patients with ankylosing spondylitis treated with tumor necrosis factor inhibitors in Korea: A multicenter cross-sectional observational study.

Authors:  Sang-Hoon Lee; Yong-Gil Kim; Seung-Geun Lee; Soo Hyun Lee; Young-Joo Kim; Ja-Young Jeon; Joo-Young Jo; Hyun-Jeong Yoo; Juneyoung Lee; Tae-Hwan Kim
Journal:  Int J Rheum Dis       Date:  2022-02-20       Impact factor: 2.558

2.  Low starting dosage of infliximab with possible escalating dosage in psoriatic arthritis gives the same treatment results as standard dosage of adalimumab or etanercept: results from the nationwide Icelandic ICEBIO registry.

Authors:  Bjorn Gudbjornsson; Arni Jon Geirsson; Niels Steen Krogh
Journal:  Psoriasis (Auckl)       Date:  2018-05-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.